In 2023, the mortality rate from liver malignant neoplasms in Canada stood at 5.5 female deaths per hundred thousand women. Forecasts for 2024 indicate a slight increase to 5.6, with a consistent upward trend projected through 2028 reaching 5.8. This reflects a modest year-on-year increment of approximately 1.8% from 2023 to 2024, stabilizing around similar percentages annually thereafter.

Future trends to watch for include:

Ongoing advancements in medical treatments that could influence mortality rates positively.
Public health campaigns and prevention strategies aimed at addressing risk factors such as alcohol consumption and hepatitis infections.
Potential demographic shifts and their impact on liver cancer incidence and mortality rates.